What is Global Pharmaceutical Starch Market?
The Global Pharmaceutical Starch Market is a vast and dynamic sector that plays a crucial role in the pharmaceutical industry. This market revolves around the production and distribution of pharmaceutical-grade starch, which is a key ingredient in many medications. The starch is derived from various sources and is used in the formulation of tablets, capsules, and other pharmaceutical products. In 2023, the market was valued at a whopping US$ 1127.4 million and is projected to reach US$ 1820.4 million by 2030. This indicates a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period from 2024 to 2030.
Corn Starch, Potato Starch, Others in the Global Pharmaceutical Starch Market:
The Global Pharmaceutical Starch Market is segmented based on the source of the starch. The primary sources include corn starch, potato starch, and others. Corn starch is a commonly used pharmaceutical excipient due to its excellent binding and disintegrating properties. It is used in the production of tablets and capsules. Potato starch, on the other hand, is known for its high viscosity and gel strength, making it ideal for use in granular formulations. Other sources of starch include wheat, rice, and tapioca. Each type of starch has unique properties that make it suitable for specific applications in the pharmaceutical industry.
Tablets, Capsule, Granular Formulation, Others in the Global Pharmaceutical Starch Market:
The Global Pharmaceutical Starch Market finds its applications in various areas of the pharmaceutical industry. The most significant usage is in the production of tablets. Starch is used as a binder and disintegrant in tablet formulations, contributing to the tablet's hardness and disintegration time. It is also used in capsule formulations, where it acts as a filler and disintegrant. In granular formulations, starch is used as a binder and helps in the controlled release of the drug. Other applications of pharmaceutical starch include its use in liquid formulations, where it acts as a thickening agent, and in topical formulations, where it serves as a dusting powder.
Global Pharmaceutical Starch Market Outlook:
The Global Pharmaceutical Starch Market is a dynamic and evolving sector. In 2019, the top five players in this market accounted for about 15.29% of the total market revenue. This indicates that the market is not concentrated and is still to be dispersed. The largest consumer group of pharmaceutical starch is the tablet sector, which accounted for 57.1% of the consumption market share in 2019. This was followed by the capsule sector, which accounted for 22.3%. In terms of geographical distribution, the United States was the largest consumer of pharmaceutical starch, accounting for about 30.1% of the market share in 2019. China was the second-largest consumer, with a market share of 9.7% in 2019.
| Report Metric | Details |
| Report Name | Pharmaceutical Starch Market |
| Accounted market size in 2023 | US$ 1127.4 million |
| Forecasted market size in 2030 | US$ 1820.4 million |
| CAGR | 7.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Tereos, Cargill, Roquette, Visco Starch, Colorcon, Agrana, Paramesu Biotech, Shandong Liaocheng E Hua Pharmaceutical, SPAC Starch Products (India) Limited, Sanstar Biopolymers Ltd, Ingredion, Shandong Liujia, Universal Starch-Chem Allied Ltd, Hunan Er-Kang Pharmaceutical, Jiangxi Yipusheng Pharmaceutical, Shanxi Mr G Pharmaceutical, Shivangan Food & Pharma, Splenor Starch LLP, Weifang Shengtai Medicine, Taishan Jinantang, Anhui Sunhere Pharmaceutical Excipients |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
